Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 65.98
-2.96 (-4.29%)
At close: Mar 9, 2026
SHE:301033 Market Cap
SHE:301033 has a market cap or net worth of 4.40 billion as of March 9, 2026. Its market cap has increased by 52.33% in one year.
Market Cap
4.40B
Enterprise Value
4.15B
Revenue
336.73M
Ranking
n/a
PE Ratio
42.81
Stock Price
65.98
Market Cap Chart
Since July 26, 2021, SHE:301033's market cap has decreased from 4.69B to 4.40B, a decrease of -6.22%. That is a compound annual growth rate of -1.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.40B | -2.25% |
| Dec 31, 2025 | 4.50B | 61.81% |
| Dec 31, 2024 | 2.78B | -3.27% |
| Dec 29, 2023 | 2.88B | 18.06% |
| Dec 30, 2022 | 2.44B | -39.66% |
| Dec 31, 2021 | 4.04B | -13.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou AGS MedTech | 4.69B |
| Zhejiang Orient Gene Biotech | 4.50B |
| Shanghai Kinetic Medical | 4.43B |
| CareRay Digital Medical Technology | 4.94B |
| Nanjing Medlander Medical Technology | 4.25B |
| Getein Biotech | 4.25B |
| Ningbo David Medical Device | 4.11B |
| Wuhan Easy Diagnosis Biomedicine | 4.06B |